Interventional Cardiology News and Research

RSS

Lowering door-to-balloon times helps benefit STEMI patients, study finds

While all heart attacks have the potential to be deadly, one type is referred to as the "widow maker" because of its high risk of death. A ST segment elevation myocardial infarction is a severe type of heart attack that occurs when a blockage in a coronary artery causes heart muscle to die; without prompt treatment risk of fatality increases dramatically. Coronary angioplasty, or percutaneous coronary intervention, is the most common emergency treatment for STEMI.

30 Apr 2013

Annual scientific symposium of the Cardiovascular Research Foundation celebrates its 25th anniversary

Media registration is now open online for TCT 2013 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation. Celebrating its 25th anniversary this year, the theme of TCT 2013 is envisioning the future, with a focus on innovation in medicine and technology.

26 Apr 2013

Loyola University Medical Center physicians deploy aortic valve through patient's abdomen

In a first-of-its-kind procedure in the United States, Loyola University Medical Center physicians have deployed an aortic valve by going through a patient's abdomen.

18 Apr 2013

Study: Patients who suffer STEMI heart attacks while hospitalized are 10 times more likely to die

If you suffer a heart attack while walking down the street and are taken to the hospital quickly, your chances of survival are very good. But if you have a heart attack while already in the hospital for something else, you are 10 times more likely to die.

18 Apr 2013

Argon Medical Devices releases OptionELITE Retrievable Vena Cava Filter

Continuing our commitment to provide best-in-class medical devices for the prevention of recurrent pulmonary embolism, Argon Medical Devices, Inc. takes another step forward with the launch of the Option™ELITE Retrievable Vena Cava Filter.

4 Apr 2013

Cedars-Sinai surgeons perform more adult heart transplants in 2012, statistics show

For the third year in a row, the Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed more adult heart transplants than any other U.S. medical center, according to statistics compiled by the United Network for Organ Sharing, the nonprofit organization that manages the nation's transplant system.

21 Mar 2013

Cangrelor solidly outperforms clopidogrel during percutaneous coronary intervention

The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large global trial of patients who underwent coronary stent procedures, according to data from the phase III CHAMPION PHOENIX study presented today at the American College of Cardiology's 62nd Annual Scientific Session.

12 Mar 2013

Abbott Vascular designates Montreal Heart Institute as a Center of Excellence

The Montreal Heart Institute has just been designated as a Center of Excellence by Abbott Vascular for the percutaneous treatment of mitral valve failure with their MitraClip system. The MHI has therefore become a reference centre for this procedure for all hospitals across Canada and many other hospitals in North America.

29 Jan 2013

Wiley publishes 4th Edition of Tips and Tricks

Wiley is pleased to announce the publication of the 4th Edition of the Practical Handbook of Advanced Interventional Cardiology: Tips and Tricks. Written and edited by today's most-recognized interventional cardiology thought leaders, this guide for interventional cardiologists focuses on key procedures and techniques and provides "tips and tricks" gathered from the personal experience of over fifty international experts.

9 Jan 2013

FDA approves Abbott’s XIENCE Xpedition Everolimus Eluting Coronary Stent System

Abbott today announced that the XIENCE Xpedition Everolimus Eluting Coronary Stent System received U.S. Food and Drug Administration (FDA) approval and is launching immediately in the United States, providing physicians with a next-generation technology with the largest size matrix in the U.S. market.

3 Jan 2013

New analysis on global trends in medical imaging for cardiology applications

The promise of cost and clinical benefits are spurring the penetration of imaging modalities in cardiac applications. While demographics are favouring market growth, cardiac imaging device manufacturers will have to focus on innovative, patient-friendly products that promote greater safety and easier operability.

2 Jan 2013

Heart attack centres: an interview with Dr Sayan Sen

Heart attack networks are designed to facilitate the rapid transfer of heart attack patients to centres with facilities that allow the manual unblocking of the coronary artery with angioplasty.

3 Dec 2012

New heart valve procedure saves life of 94-year old with aortic stenosis

94-year old Santa Monica resident Vivian Valentine has much to be thankful for this Thanksgiving. A new life-saving heart valve procedure done without traditional open heart surgery has given her a new lease on life.

20 Nov 2012

PFO closure with investigational device may prevent cryptogenic ischemic stroke

A clinical trial indicates that using an investigational medical device to close a PFO, or "hole in the heart," may be superior to medical management alone in the prevention of a repeated stroke.

26 Oct 2012

FFR-guided PCI appears to be economically attractive than medical therapy for stable CAD

A strategy of up-front percutaneous coronary intervention (PCI) for lesions confirmed to be obstructive by fractional flow reserve (FFR) was shown to be cost-effective in terms of quality-adjusted life years when compared to medical therapy alone.

26 Oct 2012

Gender gap in myocardial infarction mortality

Women are more likely to die from a myocardial infarction than men, according to research presented at the Acute Cardiac Care Congress 2012. The gender gap in mortality was independent of patient characteristics, revascularisation delays and revascularisation modalities.

20 Oct 2012

Final results from Covidien’s DEFINITIVE LE study on peripheral arterial disease

Covidien, a leading global provider of healthcare products, today announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of SilverHawk / TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities) study.

11 Oct 2012

Merit Medical Systems, Catheter Connections enter DualCap distribution agreement

Catheter Connections, Inc., a leading developer of disposable devices for preventing blood stream infections caused by vascular access devices, today announced that it entered into an exclusive distribution agreement with Merit Medical Systems, Inc., a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology and radiology.

29 Aug 2012

Agenda now available for Transcatheter Cardiovascular Therapeutics symposium

TCT 2012 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation will provide significant clinical research updates to technologies and practices in interventional cardiology that will directly affect patient care.

23 Aug 2012

UCLA performs first transcatheter aortic valve replacement using new device

UCLA has performed its first transcatheter aortic valve replacement (TAVR), using a new device approved by the U.S. Food and Drug Administration to replace an aortic valve in a patient who was not a candidate for open-heart surgery. The procedure took place August 9th.

16 Aug 2012